The IMPERIA Delivery System, a solution by NVT GmbH, is specifically engineered for the efficient transfemoral implantation of the ALLEGRA Transcatheter Heart Valve. This advanced system is distinguished by its capacity for precise commissural alignment, a critical factor in successful valve implementation. Enabled by six radiopaque markers, the system facilitates the accurate alignment of the valve during the deployment process. Among its notable features is the ability to achieve up to 80% valve deployment with the option for recapture, repositioning, or full retrieval if needed, thus ensuring predictable outcomes without valve movement upon detachment. The system is linked with various studies that have evaluated its clinical performance and hydrodynamic function. The ALLEGRA device and IMPERIA System bear CE approval, affirming their compliance with European health and safety standards. Commercialization of these medical devices is supported by collaboration between NVT GmbH and Biosensors International Group, with distribution limited to regions where healthcare authorities have granted product registration.